Age-related macular degeneration (AMD) is a leading cause of loss of central, high-acuity vision, especially in those aged 65 years and older. The two forms of the disease are dry (atrophic) AMD and wet (neovascular) AMD. Treatment with intravitreal anti-vascular endothelial growth factor injections may prevent some patients with advanced wet AMD from progressing to complete loss of central vision. Primary care clinicians play a vital role in early recognition of AMD and referral to ophthalmologists. In this activity, a specialist in AMD management discusses the pathophysiology of the disease, its clinical manifestations, and available treatment options.
eNewsletter with interactive benchmarking and audio commentary
After completing this activity, participants should be better able to:
- Describe clinical manifestations of AMD in order to recognize patients who need treatment
- Identify appropriate treatment strategies for patients with AMD
- Recommend lifestyle and dietary changes to patients to reduce the risk of progression to advanced AMD
NPs and PAs
Joint Accreditation Statement
In support of improving patient care, Practicing Clinicians Exchange is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
ANCC Credit Designation
Nursing contact hours: 1.00, which includes 1.00 hours of pharmacology credit
Nurse Planner: Rolly Coronica, DNP, FNP-C, CRNO, Veterans Administration Health Care System, Martinez, California
AAPA Credit Designation
Practicing Clinicians Exchange has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credit. Approval is valid until September 29, 2021. PAs should only claim credit commensurate with the extent of their participation.
IPCE Credit Designation
This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.
This activity is supported by an educational grant from Regeneron Pharmaceuticals, Inc.
The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Practicing Clinicians Exchange or any educational supporter.
All faculty and planners participating in continuing education activities sponsored by Practicing Clinicians Exchange are required to disclose to the audience any relevant support or substantial relationships with providers of commercial products and/or devices discussed in this activity and/or with any commercial supporters of the activity. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and planning committee have been advised that this activity must be free from commercial bias, and based upon all the available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
Dr Vemulakonda has no relevant financial relationships to disclose.
None of the members of the Planning Committee or PCE staff have any relevant relationships to disclose.
Participants wishing to earn CE/CME credit must:
- Read the content in its entirety
- Relate the content material to the learning objectives
- Complete the post-test and evaluation form
Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of at least 70%.
The estimated time to complete this activity is 1.00 hours.
Release date: September 30, 2020
Expiration date: September 29, 2021
© 2020 Practicing Clinicians Exchange. All Rights Reserved. 98720RG